RE:RE:RE:Emerging COVID serology market ripe for disruptionThanks for sharing this link.
Could be a speed bump or could be a table setter for the PMN/BCNI test, given that they have been studying this correlation for a year or so. But it would explain the language in the recent PR.
I still think the March 17 FDA posting of the Template for Test Developers of Serology Tests that Detect or Correlate to Neutralizing Antibodies (March 17, 2021) bodes well for PMN's outlook here. I also think the posting of another Template on home specimen collection just one week later also bodes well. My sense is that PMN's technology is influencing the FDA process, and perhaps even this most recent announcement.
It is interesting that the FDA announcement was specific to 'currently authorized tests.' I don't think we fall into that category yet... hopefully soon though.
Also, I do not recall ever seeing PMN mentioned on the covidimmunitypassport website... only BCNI and Immusafe, which are still mentioned in the About Us section.
Hopefully we get some more updates this week (but not tomorrow because it is Memorial Day in the US and our markets are rightfully closed).
Cheers.